Company EuBiologics Co., Ltd.

Company EuBiologics Co., Ltd.

A206650

KR7206650004

Pharmaceuticals

Equities

A206650

KR7206650004

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Biopharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Biopharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
13,540 ^KRW	+1.12%		-2.66%	+18.05%

Jan. 29	Zimbabwe launches door-to-door cholera vaccination campaign	RE
2023	Pop Biotechnologies and Eubiologics' Eucorvac-19 Vaccine Hits Target in Phase 3 Trial	CI

EuBiologics Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceuticals. The Company operates its business through two segments. The Vaccine segment manufactures and sells oral cholera vaccines. The Contract Research and Manufacturing Organization (CRMO) segment contracts, researches and manufactures biopharmaceuticals.

KRW in Million	2022	Weight	2023	Weight	Delta
Biological Products and Medical Supplies 100.0 %	55,467	100.0 %	69,366	100.0 %	+25.06%

KRW in Million	2022	Weight	2023	Weight	Delta
Africa 81.3 %	29,920	53.9 %	56,422	81.3 %	+88.58%
Middle East 8.6 %	5,980	10.8 %	5,932	8.6 %	-0.79%
South America 3.6 %	-	-	2,509	3.6 %	-
South Korea 3.6 %	4,471	8.1 %	2,507	3.6 %	-43.93%
Others 2.5 %	1,952	3.5 %	1,763	2.5 %	-9.68%
Asia 0.3 %	13,145	23.7 %	233	0.3 %	-98.23%

Managers	Title	Age	Since
Yeong-Ok Baek CEO	Chief Executive Officer	61	04-12-31
Suk-Keun Choi DFI	Director of Finance/CFO	57	10-07-31
Kyeong-Ho Min BRD	Director/Board Member	55	10-11-30
Byung-Ho Choi AUD	Comptroller/Controller/Auditor	73	-
Chan-Gyu Lee PRN	Corporate Officer/Principal	54	15-04-30
Young-Shin Park PRN	Corporate Officer/Principal	53	11-01-31

Members of the board	Title	Age	Since
Suk-Keun Choi DFI	Director of Finance/CFO	57	10-07-31
Yeong-Ok Baek CEO	Chief Executive Officer	61	04-12-31
Kyeong-Ho Min BRD	Director/Board Member	55	10-11-30
Young-Shin Park PRN	Corporate Officer/Principal	53	11-01-31
Duk-Sang Kim BRD	Director/Board Member	60	-
Glenn Rockman Anthony BRD	Director/Board Member	43	-
Seong-Muk Park BRD	Director/Board Member	52	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	36,484,307	29,237,038 ( 80.14 %)	0	80.14 %

Name	Equities	%	Valuation
Young-Sik Cho 18.43 %	6,719,153	18.43 %	60 M ₩
Wonik Investment Partners Co., Ltd. 4.465 %	1,627,659	4.465 %	15 M ₩
Duk-Sang Kim 3.884 %	1,416,060	3.884 %	13 M ₩
Yeong-Ok Baek 2.587 %	942,967	2.587 %	8 M ₩
Young-Shin Park 0.4663 %	170,000	0.4663 %	2 M ₩
Kyeong-Ho Min 0.3203 %	116,753	0.3203 %	1 M ₩
Soo-hi Jeon 0.1729 %	63,021	0.1729 %	567 365 ₩
Seok-gyu Kim 0.1569 %	57,202	0.1569 %	514 978 ₩
Chan-Gyu Lee 0.1442 %	52,552	0.1442 %	473 115 ₩
Jong-Ho Park 0.1138 %	41,500	0.1138 %	373 616 ₩

EuBiologics Co., Ltd.

6/F, Bomnal-A-Chim Building 8 Mabang-ro

06778, Seoul

http://www.eubiologics.com

Estimates Revisions

Company calendar

	1st Jan change	Capi.
EUBIOLOGICS CO., LTD.	+18.05%	365M
CSL LIMITED	-3.79%	88.14B
SAMSUNG BIOLOGICS CO.,LTD.	+1.45%	40.51B
BIOGEN INC.	-15.94%	31.67B
UCB	+52.66%	24.62B
BIOMARIN PHARMACEUTICAL INC.	-14.50%	15.65B
INCYTE CORPORATION	-14.38%	12.07B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.97B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61B
SWEDISH ORPHAN BIOVITRUM AB	+4.87%	8.81B

Biopharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals